Pure Global

Aspergilus Galactomannan Lateral Flow Assay - India CDSCO Medical Device Registration

Aspergilus Galactomannan Lateral Flow Assay is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000296_a253976b943e870d9dee7a07b87393f8_bfd95e1b51dff54e4a852df4aec3941d. This device is marketed under the brand name sona Aspergillus GM LFA. The license holder is Taevas Life Sciences Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Aspergilus Galactomannan Lateral Flow Assay
UID: IMP/IVD/2019/000296_a253976b943e870d9dee7a07b87393f8_bfd95e1b51dff54e4a852df4aec3941d

Brand Name

sona Aspergillus GM LFA

Device Class

Class C

Approving Authority

CDSCO

Product Information

The sona Aspergillus Galactomannan Lateral Flow Assay (sona Aspergillus GM LFA) is an immunochromatographic test system for the qualitative detection of Aspergillus Galactomannan in serum and BAL samples. The sona Aspergillus GM LFA is a test which, when used in conjunction with other diagnostic procedures such as microbiological culture, histological examination of biopsy samples, and radiographic evidence, can be used as an aid in the diagnosis of aspergillosis

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Similar Products (1)
Other products with the same name or brand